Core Laboratories (NYSE:CLB) Posts Earnings Results, Hits Estimates

Key Points

• Q1 results delivered $0.06 EPS in line with estimates but revenue of $121.8M slightly missed consensus, and management issued weaker Q2 guidance of $0.06–$0.12 EPS with revenue guidance below street expectations, triggering a sharp share decline.
• Underlying metrics show pressure on profitability and cash flow — operating income was only $1.9M, GAAP showed a $0.02 loss per share, free cash flow fell to $0.5M, and net debt rose by $3.9M — reducing near-term financial flexibility.
• Shareholder returns remain modest: a $0.01 quarterly dividend (0.3% yield) and roughly $0.9M of buybacks in Q1, while institutional ownership is high (~97.8%) and analysts maintain an average "Hold" rating with a $12.50 target.

Core Laboratories (NYSE:CLB - Get Free Report) released its quarterly earnings results on Wednesday. The oil and gas company reported $0.06 earnings per share for the quarter, meeting analysts' consensus estimates of $0.06, FiscalAI reports. The business had revenue of $121.80 million for the quarter, compared to the consensus estimate of $122.99 million. Core Laboratories had a return on equity of 12.18% and a net margin of 6.04%.The company's revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter last year, the business posted $0.14 earnings per share. Core Laboratories updated its Q2 2026 guidance to 0.060-0.120 EPS.

Core Laboratories Price Performance

NYSE:CLB traded down $2.65 on Thursday, reaching $14.66. 453,285 shares of the company's stock traded hands, compared to its average volume of 384,677. The company has a quick ratio of 1.51, a current ratio of 2.02 and a debt-to-equity ratio of 0.41. The stock has a 50-day simple moving average of $16.74 and a 200-day simple moving average of $16.69. The firm has a market cap of $674.86 million, a PE ratio of 21.89, a P/E/G ratio of 3.25 and a beta of 1.15. Core Laboratories has a 12 month low of $9.72 and a 12 month high of $20.36.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Monday, May 11th will be issued a dividend of $0.01 per share. The ex-dividend date of this dividend is Monday, May 11th. This represents a $0.04 dividend on an annualized basis and a yield of 0.3%. Core Laboratories's dividend payout ratio (DPR) is currently 5.97%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a "hold (c)" rating on shares of Core Laboratories in a research note on Friday, March 27th. Four research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $12.50.

Institutional Investors Weigh In On Core Laboratories

Institutional investors and hedge funds have recently bought and sold shares of the business. Corient Private Wealth LLC purchased a new position in shares of Core Laboratories during the fourth quarter valued at about $219,000. T. Rowe Price Investment Management Inc. grew its position in Core Laboratories by 14.8% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 1,042,208 shares of the oil and gas company's stock worth $16,707,000 after acquiring an additional 134,050 shares in the last quarter. XTX Topco Ltd lifted its stake in Core Laboratories by 110.9% in the fourth quarter. XTX Topco Ltd now owns 54,273 shares of the oil and gas company's stock worth $870,000 after purchasing an additional 28,541 shares during the last quarter. Old West Investment Management LLC bought a new stake in shares of Core Laboratories during the fourth quarter valued at approximately $613,000. Finally, AQR Capital Management LLC increased its stake in shares of Core Laboratories by 32.6% during the fourth quarter. AQR Capital Management LLC now owns 49,818 shares of the oil and gas company's stock valued at $799,000 after buying an additional 12,242 shares during the period. 97.81% of the stock is owned by institutional investors.

Trending Headlines about Core Laboratories

Here are the key news stories impacting Core Laboratories this week:

• Positive Sentiment: Board-authorized capital returns: management repurchased 51,781 shares for roughly $0.9 million in Q1, showing continued buyback activity that supports shareholder value. PR Newswire Release
• Positive Sentiment: Quarterly dividend declared: Core announced a $0.01 per-share quarterly dividend (ex-dividend May 11; payable June 1), providing a modest yield and signaling some shareholder-return discipline.
• Neutral Sentiment: Reported EPS in line with expectations: CLB posted $0.06 EPS for Q1, meeting consensus estimates — a stabilization versus steeper sequential declines implied by other metrics. Quarterly Report
• Neutral Sentiment: Coverage and comparisons: industry write-ups and value-comparison pieces (e.g., TipRanks, Zacks) are examining CLB vs peers, which may attract bargain-hunting interest but do not change near-term fundamentals. TipRanks Article Zacks Article
• Negative Sentiment: Weaker Q2 guidance: management set Q2 EPS guidance of $0.060–$0.120 vs. the consensus ~$0.150 and revenue guidance below street expectations ($123M–$131M vs. ~$127.8M), signaling softer near-term demand and driving the share decline.
• Negative Sentiment: Revenue and profitability pressures: Q1 revenue was $121.8M (below analyst estimates), operating income was only $1.9M and GAAP reported a $0.02 loss per share; adjusted EPS and ex-items fell substantially year-over-year and sequentially. PR Newswire Release
• Negative Sentiment: Weak cash flow and higher leverage: free cash flow dropped to $0.5M and net debt increased by $3.9M (leverage ~1.20), reducing financial flexibility and raising near-term execution risk.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company's portfolio spans two primary service lines: reservoir description and production enhancement.